Hormesis and Cellular Quality Control: A Possible Explanation for the Molecular Mechanisms that Underlie the Benefits of Mild Stress von Wiegant, F.A.C., Poot, S.A.H. de, Boers-Trilles, V.E., Schreij, A.M.A

Volltext

HTA218 Public Engagement and Its Influence on Health Technology Assessment Outcomes in Latin America von Tôrres, L., Nacazume, J., Vega, M., Boers Trilles, V., Bustamante, M., Ribeiro, A.

Volltext

PNS72 From Volume-to-VALUE in Latin America: A 6-STEP Process von Guarin, D., Bustos Márquez, M.C., Izquierdo Albero, R., Boers Trilles, V., Martin De Bustamante, M.

Volltext

PMU9 ESTABLISHING CHILE RICARTE SOTO LAW REIMBURSEMENT CAP IN THE FACE OF GENERIC COMPETITION von Boers Trilles, V., Martin De Bustamante, M.

Volltext

PIN63 Choosing the Right COVID-19 Vaccine: A Multiple Stakeholder Multicriteria Decision Analysis For the Assessment of Available Vaccines in Latin America von Espinoza, M.A., Guzman, J., Soto, J., Hernandez, G., Guarin, D., Boers Trilles, V., Martin De Bustamante, M.

Volltext

HTA33 Lung Cancer Health Technology Assessments Trends in Argentina, Brazil, Colombia, and Mexico von Wurcel, V, Criniti, JM, Riveros B, Salgado, Garmatter L, Leonart, Rosim, M, Almeida, A, Urrego-Reyes, J., Arnedo CA, Marrugo, Acevedo, R, Junqueira, M, Amaya-Gutierrez, M.J., Bustamante, M, Trilles V, Boers, Murasawa, W, Tôrres, L, Villavicencio, D

Volltext

PNS101 COLLABORATIVE APPROACHES TO ATTAIN HEALTHCARE SUSTAINABILITY IN LATIN AMERICA von Guarin, D.F., Chavez, R., Trujillo de Hart, J.C., Graham, N., Boers Trilles, V., Martin De Bustamante, M.

Volltext

PHP180 - ACCESS AND VALUE OF HEALTHCARE INNOVATION IN LATIN AMERICA von Martin de Bustamante, M., Alfonso, R., Boers Trilles, V., Guarin, D.F.

Volltext

PNS32 COMPARATIVE ANALYSIS OF TENDER LEGISLATION IN BRAZIL AND MEXICO von Boers Trilles, V., Favetta, B., Martin De Bustamante, M.

Volltext

PMU11 COMPARATIVE ASSESSMENT OF HTA OUTCOMES IN BRAZIL, CANADA AND THE UNITED KINGDOM von Boers Trilles, V., Ayoub, R., Favetta, B., Graham, N., Martin De Bustamante, M.

Volltext

PNS2 COLOMBIA'S HEALTHCARE REFORM: COST-CONTAINMENT MECHANISMS AND IMPLICATIONS FOR SUSTAINABILITY von Boers Trilles, V., Favetta, B., Du, A., Martin De Bustamante, M.

Volltext

PNS3 BRAZILIAN PHARMACEUTICAL INDUSTRY: THE IMPACT OF PUBLIC POLICIES AIMED AT FOSTERING LOCAL MANUFACTURING von Boers Trilles, V., Ayoub, R., Favetta, B., Martin De Bustamante, M.

Volltext

PCN45 COMPARATIVE ANALYSIS OF BRA CMED, GER G-BA AND FRA HAS ASSESSMENT SCORES FOR ONCOLOGY THERAPIES von Boers Trilles, V., Favetta, B., Graham, N., Martin De Bustamante, M.

Volltext

PCN3 BRAND-BRAND ONCOLOGY COMBINATIONS: HURDLES AND IMPLICATIONS von Boers Trilles, V., Favetta, B., Garcia, E., Graham, N., Martin De Bustamante, M.

Volltext

RE4 PROPOSED SOLUTIONS TO ACHIEVING HEALTHCARE SUSTAINABILITY IN LATIN AMERICA von Guarin, D.F., Matus, A., Toro, W., Trujillo de Hart, J.C., Boers Trilles, V., McGahan, S., Graham, N., Martin De Bustamante, M.

Volltext